In contrast to breast carcinoma cells, pan-HDAC blockade with LBH589 did not upregulate PPARγ expression or augment its activity in untransformed human breast epithelial cell lines MCF10A and MCF12A (Fig. S8A, B). This evidence concerns the gene HDAC9 and breast carcinoma.